$24.77
+0.35
(+1.43%)▲
0.55%
Downside
Day's Volatility :4.03%
Upside
3.51%
51.35%
Downside
52 Weeks Volatility :62.47%
Upside
22.86%
Period | Phreesia, Inc. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 18.49% | 6.5% | 0.0% |
6 Months | -3.29% | 7.1% | 0.0% |
1 Year | -21.17% | 9.8% | 0.0% |
3 Years | -63.09% | 14.2% | -20.2% |
Market Capitalization | 1.4B |
Book Value | $4.41 |
Earnings Per Share (EPS) | -2.16 |
Wall Street Target Price | 29.07 |
Profit Margin | -31.87% |
Operating Margin TTM | -46.68% |
Return On Assets TTM | -19.51% |
Return On Equity TTM | -46.12% |
Revenue TTM | 373.7M |
Revenue Per Share TTM | 6.75 |
Quarterly Revenue Growth YOY | 45.7% |
Gross Profit TTM | 171.6M |
EBITDA | -93.8M |
Diluted Eps TTM | -2.16 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.23 |
EPS Estimate Next Year | -0.36 |
EPS Estimate Current Quarter | -0.48 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 17.36%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 99.9M | ↑ 25.12% |
Net Income | -15.1M | ↓ 17.21% |
Net Profit Margin | -15.08% | ↑ 7.71% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 124.8M | ↑ 24.92% |
Net Income | -20.3M | ↑ 34.73% |
Net Profit Margin | -16.26% | ↓ 1.18% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 148.7M | ↑ 19.15% |
Net Income | -27.3M | ↑ 34.49% |
Net Profit Margin | -18.36% | ↓ 2.1% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 213.2M | ↑ 43.42% |
Net Income | -118.2M | ↑ 332.95% |
Net Profit Margin | -55.41% | ↓ 37.05% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 280.9M | ↑ 31.74% |
Net Income | -176.1M | ↑ 49.07% |
Net Profit Margin | -62.71% | ↓ 7.3% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 356.3M | ↑ 26.84% |
Net Income | -136.9M | ↓ 22.29% |
Net Profit Margin | -38.42% | ↑ 24.29% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 76.6M | ↑ 4.76% |
Net Income | -38.0M | ↓ 5.34% |
Net Profit Margin | -49.64% | ↑ 5.31% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 83.8M | ↑ 9.48% |
Net Income | -37.5M | ↓ 1.29% |
Net Profit Margin | -44.76% | ↑ 4.88% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 85.8M | ↑ 2.37% |
Net Income | -36.8M | ↓ 2.04% |
Net Profit Margin | -42.84% | ↑ 1.92% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 91.6M | ↑ 6.74% |
Net Income | -31.9M | ↓ 13.13% |
Net Profit Margin | -34.86% | ↑ 7.98% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 95.0M | ↑ 3.7% |
Net Income | -30.6M | ↓ 4.05% |
Net Profit Margin | -32.26% | ↑ 2.6% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 101.2M | ↑ 6.54% |
Net Income | -19.7M | ↓ 35.65% |
Net Profit Margin | -19.48% | ↑ 12.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 59.3M | ↑ 3.72% |
Total Liabilities | 270.2M | ↑ 20.2% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 158.8M | ↑ 167.89% |
Total Liabilities | 56.9M | ↓ 78.95% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 326.7M | ↑ 105.76% |
Total Liabilities | 63.4M | ↑ 11.37% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 494.5M | ↑ 51.37% |
Total Liabilities | 77.2M | ↑ 21.84% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 370.1M | ↓ 25.16% |
Total Liabilities | 82.2M | ↑ 6.53% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 371.1M | ↑ 0.28% |
Total Liabilities | 119.6M | ↑ 45.48% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 370.1M | ↓ 6.86% |
Total Liabilities | 82.2M | ↑ 6.87% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 353.9M | ↓ 4.38% |
Total Liabilities | 90.2M | ↑ 9.73% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 340.4M | ↓ 3.79% |
Total Liabilities | 93.4M | ↑ 3.53% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 374.6M | ↑ 10.05% |
Total Liabilities | 110.0M | ↑ 17.8% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 371.1M | ↓ 0.95% |
Total Liabilities | 119.6M | ↑ 8.71% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 372.1M | ↑ 0.27% |
Total Liabilities | 119.3M | ↓ 0.24% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -2.1M | ↓ 80.88% |
Investing Cash Flow | -11.0M | ↓ 7.87% |
Financing Cash Flow | 4.2M | ↓ 86.6% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 826.0K | ↓ 138.78% |
Investing Cash Flow | -12.3M | ↑ 11.77% |
Financing Cash Flow | 100.3M | ↑ 2291.04% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.9M | ↑ 249.88% |
Investing Cash Flow | -25.1M | ↑ 103.61% |
Financing Cash Flow | 150.7M | ↑ 50.26% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -74.7M | ↓ 2685.12% |
Investing Cash Flow | -65.2M | ↑ 160.03% |
Financing Cash Flow | 235.0M | ↑ 55.96% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -90.1M | ↑ 20.63% |
Investing Cash Flow | -26.2M | ↓ 59.83% |
Financing Cash Flow | -20.4M | ↓ 108.68% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -15.9M | ↓ 23.37% |
Investing Cash Flow | -6.6M | ↓ 1.92% |
Financing Cash Flow | -10.0M | ↑ 173.23% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -13.7M | ↓ 14.09% |
Investing Cash Flow | -6.1M | ↓ 7.88% |
Financing Cash Flow | -7.2M | ↓ 28.3% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -9.3M | ↓ 31.69% |
Investing Cash Flow | -15.8M | ↑ 159.83% |
Financing Cash Flow | -3.0M | ↓ 57.61% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -6.3M | ↓ 32.38% |
Investing Cash Flow | -15.7M | ↓ 0.49% |
Financing Cash Flow | -2.3M | ↓ 24.94% |
Sell
Neutral
Buy
Phreesia, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Phreesia, Inc. | 12.07% | -3.29% | -21.17% | -63.09% | -8.57% |
![]() Solventum Corp | 13.4% | -16.71% | -16.71% | -16.71% | -16.71% |
![]() Veeva Systems Inc. | 1.24% | -10.63% | -7.18% | -43.19% | 9.43% |
![]() Ge Healthcare Technologies Inc. | 2.46% | 9.25% | 3.22% | 32.12% | 32.12% |
![]() Healthequity Inc | -3.68% | 3.76% | 26.99% | 6.89% | -2.18% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Phreesia, Inc. | NA | NA | NA | -1.23 | -0.46 | -0.2 | NA | 4.41 |
![]() Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
![]() Veeva Systems Inc. | 54.35 | 54.35 | 1.35 | 4.76 | 0.13 | 0.06 | NA | 30.25 |
![]() Ge Healthcare Technologies Inc. | 23.5 | 23.5 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
![]() Healthequity Inc | 85.91 | 85.91 | 2.29 | 2.19 | 0.04 | 0.03 | NA | 24.11 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Phreesia, Inc. | Buy | $1.4B | -8.57% | NA | -31.87% |
![]() Solventum Corp | Hold | $10.8B | -16.71% | NA | 15.73% |
![]() Veeva Systems Inc. | Buy | $29.8B | 9.43% | 54.35 | 22.34% |
![]() Ge Healthcare Technologies Inc. | Buy | $36.9B | 32.12% | 23.5 | 8.05% |
![]() Healthequity Inc | Buy | $6.9B | -2.18% | 85.91 | 7.71% |
Insights on Phreesia, Inc.
Revenue is up for the last 18 quarters, 32.81M → 101.21M (in $), with an average increase of 6.4% per quarter
Netprofit is up for the last 9 quarters, -51.24M → -19.72M (in $), with an average increase of 13.7% per quarter
In the last 1 year, Healthequity Inc has given 27.0% return, outperforming this stock by 48.2%
In the last 3 years, Healthequity Inc has given 6.9% return, outperforming this stock by 70.0%
FMR Inc
Vanguard Group Inc
Brown Advisory Holdings Inc
BlackRock Inc
Capital Research & Mgmt Co - Division 3
Rock Springs Capital Management LP
leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.
Organization | Phreesia, Inc. |
Employees | 1438 |
CEO | Mr. Chaim Indig |
Industry | Technology Services |
A Spac I Acquisition Corp
$24.77
+1.43%
Keyarch Acquisition Corp
$24.77
+1.43%
Connexa Sports Technologies Inc
$24.77
+1.43%
Us Value Etf
$24.77
+1.43%
First Wave Biopharma Inc
$24.77
+1.43%
Global X Msci Next Emerging
$24.77
+1.43%
Fat Projects Acquisition Corp
$24.77
+1.43%
Capital Link Global Fintech
$24.77
+1.43%
Applied Uv Inc
$24.77
+1.43%